Liquidata Share/ETF/Trust Analysis
Portfolio Holdings Detail for ISIN IE00BF4RFH31
| Stock Name / Fund | iShares MSCI World Small Cap UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares III Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300PZLRJB7M8H1057 |
| ETF Ticker | WSML(USD) LSE |
| ETF Ticker | WLDS(GBP) LSE |
| ETF Ticker | IUSN(EUR) F |
| ETF Ticker | IUSN.DE(EUR) CXE |
| ETF Ticker | WLDS.LS(GBP) CXE |
| ETF Ticker | WSML.LS(USD) CXE |
| ETF Ticker | WSML.L(GBP) LSE |
| ETF Ticker | WLDS.L(GBP) LSE |
Holdings detail for RNA
| Stock Name | Avidity Biosciences Inc |
| Ticker | RNA(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US05370A1088 |
Show aggregate RNA holdings
News associated with RNA
- Avidity Biosciences (NASDAQ:RNA) Coverage Initiated by Analysts at Roth Capital
- Roth Capital started coverage on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a report released on Wednesday, Marketbeat.com reports. The brokerage issued a buy rating and a $62.00 price objective on the biotechnology company’s stock. A number of other equities analysts also recently weighed in on the stock. Wolfe Research began coverage on […] - 2025-09-18 04:26:54
- Bank of America Raises Avidity Biosciences (NASDAQ:RNA) Price Target to $65.00
- Avidity Biosciences (NASDAQ:RNA – Get Free Report) had its target price raised by research analysts at Bank of America from $56.00 to $65.00 in a research report issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Bank of America‘s price objective suggests a potential upside of 56.85% from […] - 2025-09-17 02:38:42
- Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts
- The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-12 14:49:56
- Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts
- The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-12 12:32:21
- Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts
- The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-12 10:58:14
- Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts
- The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-12 10:14:12
- Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts
- The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-12 08:20:54
- Brokerages Set Avidity Biosciences, Inc. (NASDAQ:RNA) Price Target at $67.00
- Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) has been assigned a consensus rating of “Buy” from the eighteen ratings firms that are presently covering the firm, Marketbeat.com reports. Seventeen equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 […] - 2025-09-12 02:32:51
- Stocks Climb to Record Highs on the Outlook for Fed Rate Cuts
- The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.60%. September E-mini S&P futures (ESU25 ) rose +0.81%, and September E-mini Nasdaq futures... - 2025-09-11 20:38:25
- Stocks Rally and Bond Yields Fall on Fed Rate Cut Hopes
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.66%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.47%. September E-mini S&P futures (ESU25 ) are up +0.64%, and September E-mini Nasdaq futures... - 2025-09-11 20:20:22
- Stocks Climb as US Labor Market Weakness Bolsters Fed Rate Cut Expectations
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. September E-mini S&P futures (ESU25 ) are up +0.30%, and September E-mini Nasdaq futures... - 2025-09-11 19:48:54
- Stocks Rally and Bond Yields Fall on Fed Rate Cut Hopes
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.66%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.47%. September E-mini S&P futures (ESU25 ) are up +0.64%, and September E-mini Nasdaq futures... - 2025-09-11 14:56:29
- Stocks Climb as US Labor Market Weakness Bolsters Fed Rate Cut Expectations
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. September E-mini S&P futures (ESU25 ) are up +0.30%, and September E-mini Nasdaq futures... - 2025-09-11 14:56:29
- Stocks Rally and Bond Yields Fall on Fed Rate Cut Hopes
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.66%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.47%. September E-mini S&P futures (ESU25 ) are up +0.64%, and September E-mini Nasdaq futures... - 2025-09-11 14:31:03
- Stocks Climb as US Labor Market Weakness Bolsters Fed Rate Cut Expectations
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. September E-mini S&P futures (ESU25 ) are up +0.30%, and September E-mini Nasdaq futures... - 2025-09-11 14:31:02
- Stocks Climb as US Labor Market Weakness Bolsters Fed Rate Cut Expectations
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. September E-mini S&P futures (ESU25 ) are up +0.30%, and September E-mini Nasdaq futures... - 2025-09-11 12:55:25
- Stocks Climb as US Labor Market Weakness Bolsters Fed Rate Cut Expectations
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. September E-mini S&P futures (ESU25 ) are up +0.30%, and September E-mini Nasdaq futures... - 2025-09-11 12:50:08
- Avidity Biosciences (NASDAQ:RNA) Stock Price Down 4.2% After Insider Selling
- Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report)’s stock price dropped 4.2% on Monday after an insider sold shares in the company. The stock traded as low as $44.55 and last traded at $44.51. Approximately 1,095,468 shares changed hands during trading, a decline of 40% from the average daily volume of 1,834,316 shares. The stock […] - 2025-08-20 02:34:50
- Avidity Biosciences (NASDAQ:RNA) Shares Gap Down on Insider Selling
- Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report)’s stock price gapped down prior to trading on Monday after an insider sold shares in the company. The stock had previously closed at $46.29, but opened at $44.46. Avidity Biosciences shares last traded at $44.45, with a volume of 505,071 shares. Specifically, insider Steven George Hughes sold […] - 2025-08-12 02:18:50
- Barclays Increases Avidity Biosciences (NASDAQ:RNA) Price Target to $62.00
- Avidity Biosciences (NASDAQ:RNA – Free Report) had its price target boosted by Barclays from $59.00 to $62.00 in a research note released on Friday,Benzinga reports. Barclays currently has an overweight rating on the biotechnology company’s stock. A number of other brokerages also recently commented on RNA. Bank of America lifted their price objective on Avidity […] - 2025-08-11 03:50:56
- Oppenheimer Asset Management Inc. Invests $226,000 in Avidity Biosciences, Inc. (NASDAQ:RNA)
- Oppenheimer Asset Management Inc. bought a new position in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) during the first quarter, Holdings Channel reports. The fund bought 7,657 shares of the biotechnology company’s stock, valued at approximately $226,000. Several other hedge funds have also modified their holdings of the stock. Parallel Advisors LLC raised […] - 2025-07-01 04:52:51
- The Implied Analyst 12-Month Target For ESML
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-26 13:02:45
- Avidity Biosciences (NASDAQ:RNA) Now Covered by Sanford C. Bernstein
- Investment analysts at Sanford C. Bernstein began coverage on shares of Avidity Biosciences (NASDAQ:RNA – Get Free Report) in a research note issued to investors on Tuesday, MarketBeat reports. The brokerage set an “outperform” rating and a $50.00 price target on the biotechnology company’s stock. Sanford C. Bernstein’s price target indicates a potential upside of […] - 2025-06-26 02:48:48
- Avidity Biosciences (NASDAQ:RNA) Earns Outperform Rating from Analysts at Wolfe Research
- Equities research analysts at Wolfe Research assumed coverage on shares of Avidity Biosciences (NASDAQ:RNA – Get Free Report) in a research note issued on Tuesday, Marketbeat.com reports. The brokerage set an “outperform” rating and a $55.00 price target on the biotechnology company’s stock. Wolfe Research’s price objective points to a potential upside of 87.59% from […] - 2025-06-19 02:42:48
- Assenagon Asset Management S.A. Raises Stock Holdings in Avidity Biosciences, Inc. (NASDAQ:RNA)
- Assenagon Asset Management S.A. raised its position in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 411.3% during the 1st quarter, Holdings Channel reports. The fund owned 207,372 shares of the biotechnology company’s stock after purchasing an additional 166,813 shares during the period. Assenagon Asset Management S.A.’s holdings in Avidity Biosciences were worth […] - 2025-06-15 05:44:49
- Chardan Capital Forecasts Strong Price Appreciation for Avidity Biosciences (NASDAQ:RNA) Stock
- Avidity Biosciences (NASDAQ:RNA – Get Free Report) had its price objective raised by research analysts at Chardan Capital from $65.00 to $75.00 in a report released on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Chardan Capital’s price target would indicate a potential upside of 123.08% from the company’s […] - 2025-06-11 04:58:52
- Avidity Biosciences (NASDAQ:RNA) Stock Price Expected to Rise, Bank of America Analyst Says
- Avidity Biosciences (NASDAQ:RNA – Get Free Report) had its price objective hoisted by stock analysts at Bank of America from $48.00 to $54.00 in a report issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Bank of America‘s price target would indicate a potential upside of 60.62% from […] - 2025-06-11 03:00:54
- Avidity Biosciences (NASDAQ:RNA) Shares Gap Up Following Analyst Upgrade
- Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) shares gapped up before the market opened on Monday after Citigroup raised their price target on the stock from $70.00 to $75.00. The stock had previously closed at $36.24, but opened at $38.00. Citigroup currently has a buy rating on the stock. Avidity Biosciences shares last traded […] - 2025-06-11 02:08:44
- Traders Purchase Large Volume of Avidity Biosciences Put Options (NASDAQ:RNA)
- Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) was the target of unusually large options trading activity on Wednesday. Stock traders acquired 7,058 put options on the company. This is an increase of 1,411% compared to the typical daily volume of 467 put options. Avidity Biosciences Price Performance Shares of Avidity Biosciences stock opened at […] - 2025-06-06 05:14:54
- Brokerages Set Avidity Biosciences, Inc. (NASDAQ:RNA) Price Target at $66.38
- Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) has earned a consensus recommendation of “Buy” from the thirteen research firms that are currently covering the stock, MarketBeat.com reports. Thirteen research analysts have rated the stock with a buy rating. The average 12-month price target among brokerages that have issued a report on the stock in […] - 2025-06-04 02:36:49
iShares MSCI World Small Cap UCITS ETF USD (Acc) RNA holdings
| Date | Number of RNA Shares Held | Base Market Value of RNA Shares | Local Market Value of RNA Shares | Change in RNA Shares Held | Change in RNA Base Value | Current Price per RNA Share Held | Previous Price per RNA Share Held |
|---|
| 2025-10-15 (Wednesday) | 74,192 | USD 3,744,470 | USD 3,744,470 | | | | |
| 2025-10-10 (Friday) | 73,745 | USD 3,670,289 | USD 3,670,289 | | | | |
| 2025-10-08 (Wednesday) | 73,745 | USD 3,558,934 | USD 3,558,934 | | | | |
| 2025-10-07 (Tuesday) | 73,745 | USD 3,462,328 | USD 3,462,328 | 298 | USD 70,546 | USD 46.95 | USD 46.18 |
| 2025-10-06 (Monday) | 73,447 | USD 3,391,782 | USD 3,391,782 | 0 | USD -60,227 | USD 46.18 | USD 47 |
| 2025-10-03 (Friday) | 73,447 | USD 3,452,009 | USD 3,452,009 | 0 | USD 207,121 | USD 47 | USD 44.18 |
| 2025-10-02 (Thursday) | 73,447 | USD 3,244,888 | USD 3,244,888 | 0 | USD 86,667 | USD 44.18 | USD 43 |
| 2025-10-01 (Wednesday) | 73,447 | USD 3,158,221 | USD 3,158,221 | 0 | USD -41,865 | USD 43 | USD 43.57 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of RNA by Blackrock for IE00BF4RFH31
Show aggregate share trades of RNA| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-10-07 | BUY | 298 | | | 46.950* | | 34.37 |
| 2025-09-30 | BUY | 7,576 | | | 43.570* | | 34.07 |
| 2025-09-08 | SELL | -484 | | | 48.050* | | 33.80 Profit of 16,360 on sale |
| 2025-08-15 | BUY | 242 | | | 46.470* | | 33.73 |
| 2025-08-07 | BUY | 726 | | | 47.520* | | 33.57 |
| 2025-07-29 | BUY | 242 | | | 35.950* | | 33.37 |
| 2025-07-14 | BUY | 488 | | | 33.570* | | 33.37 |
| 2025-06-30 | BUY | 488 | | | 28.400* | | 33.53 |
| 2025-06-25 | BUY | 732 | | | 29.900* | | 33.61 |
| 2025-06-20 | SELL | -122 | | | 29.310* | | 33.70 Profit of 4,112 on sale |
| 2025-06-12 | SELL | -976 | | | 32.140* | | 33.86 Profit of 33,044 on sale |
| 2025-06-02 | BUY | 366 | | | 33.170* | | 33.85 |
| 2025-05-28 | BUY | 244 | | | 30.900* | | 33.91 |
| 2025-05-14 | BUY | 122 | | | 28.400* | | 34.24 |
| 2025-05-13 | BUY | 244 | | | 29.880* | | 34.28 |
| 2025-05-07 | BUY | 366 | | | 26.170* | | 34.51 |
| 2025-04-28 | BUY | 122 | | | 31.205* | | 34.73 |
| 2025-04-16 | BUY | 1,599 | | | 25.760* | | 35.25 |
| 2025-04-14 | BUY | 246 | | | 26.910* | | 35.43 |
| 2025-04-08 | SELL | -246 | | | 24.080* | | 35.93 Profit of 8,838 on sale |
| 2025-04-04 | SELL | -246 | | | 26.570* | | 36.16 Profit of 8,896 on sale |
| 2025-03-28 | BUY | 1,220 | | | 31.600* | | 36.49 |
| 2025-03-12 | SELL | -246 | | | 32.610* | | 37.28 Profit of 9,172 on sale |
| 2025-03-04 | SELL | -246 | | | 28.560* | | 37.88 Profit of 9,319 on sale |
| 2025-02-28 | SELL | -7,244 | | | 30.640* | | 38.14 Profit of 276,279 on sale |
| 2025-02-26 | SELL | -556 | | | 29.650* | | 38.43 Profit of 21,368 on sale |
| 2025-02-13 | BUY | 140 | | | 33.020* | | 39.63 |
| 2025-02-12 | BUY | 556 | | | 31.830* | | 39.78 |
| 2025-01-27 | BUY | 139 | | | 30.440* | | 41.87 |
| 2025-01-23 | BUY | 139 | | | 30.130* | | 42.54 |
| 2024-12-09 | BUY | 5,004 | | | 36.850* | | 43.69 |
| 2024-12-04 | BUY | 276 | | | 37.930* | | 44.31 |
| 2024-12-03 | BUY | 414 | | | 38.480* | | 44.52 |
| 2024-11-25 | BUY | 10,276 | | | 45.130* | | 44.85 |
| 2024-11-19 | BUY | 678 | | | 43.250* | | 45.22 |
| 2024-11-18 | BUY | 224 | | | 41.350* | | 45.45 |
| 2024-11-12 | BUY | 448 | | | 46.730* | | 45.37 |
| 2024-11-11 | BUY | 112 | | | 47.120* | | 45.25 |
| 2024-11-07 | BUY | 560 | | | 47.510* | | 44.96 |
| 2024-10-23 | BUY | 222 | | | 45.400* | | 47.05 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of RNA
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 479,193 | 730 | 670,240 | 71.5% |
| 2025-09-18 | 554,478 | 0 | 762,941 | 72.7% |
| 2025-09-17 | 562,186 | 8,483 | 864,658 | 65.0% |
| 2025-09-16 | 474,349 | 8,279 | 736,380 | 64.4% |
| 2025-09-15 | 1,254,254 | 53,512 | 2,429,041 | 51.6% |
| 2025-09-12 | 1,851,579 | 59,324 | 3,704,572 | 50.0% |
| 2025-09-11 | 2,661,160 | 79,723 | 4,334,246 | 61.4% |
| 2025-09-10 | 533,839 | 2,174 | 1,145,716 | 46.6% |
| 2025-09-09 | 711,392 | 589 | 1,263,078 | 56.3% |
| 2025-09-08 | 512,030 | 2,000 | 961,959 | 53.2% |
| 2025-09-05 | 728,043 | 8,553 | 1,497,260 | 48.6% |
| 2025-09-04 | 254,612 | 4,625 | 487,032 | 52.3% |
| 2025-09-03 | 439,832 | 2,800 | 971,692 | 45.3% |
| 2025-09-02 | 548,455 | 942 | 1,130,707 | 48.5% |
| 2025-08-29 | 347,269 | 2,984 | 585,144 | 59.3% |
| 2025-08-28 | 578,734 | 4,472 | 1,073,432 | 53.9% |
| 2025-08-27 | 336,047 | 0 | 550,225 | 61.1% |
| 2025-08-26 | 378,994 | 2,387 | 558,606 | 67.8% |
| 2025-08-25 | 291,957 | 1,364 | 443,822 | 65.8% |
| 2025-08-22 | 421,554 | 692 | 673,648 | 62.6% |
| 2025-08-21 | 266,829 | 176 | 391,203 | 68.2% |
| 2025-08-20 | 380,047 | 5,788 | 513,494 | 74.0% |
| 2025-08-19 | 407,186 | 3,755 | 777,005 | 52.4% |
| 2025-08-18 | 409,017 | 559 | 711,246 | 57.5% |
| 2025-08-15 | 644,114 | 11,248 | 1,061,732 | 60.7% |
| 2025-08-14 | 518,133 | 4,263 | 934,468 | 55.4% |
| 2025-08-13 | 470,039 | 6,345 | 1,247,535 | 37.7% |
| 2025-08-12 | 644,525 | 1,910 | 1,247,028 | 51.7% |
| 2025-08-11 | 630,303 | 1,012 | 1,400,171 | 45.0% |
| 2025-08-08 | 1,234,510 | 7,440 | 1,550,082 | 79.6% |
| 2025-08-07 | 968,859 | 9,462 | 1,759,643 | 55.1% |
| 2025-08-06 | 4,793,692 | 51,980 | 7,935,195 | 60.4% |
| 2025-08-05 | 629,962 | 300 | 815,840 | 77.2% |
| 2025-08-04 | 714,343 | 2,536 | 909,307 | 78.6% |
| 2025-08-01 | 617,309 | 125 | 914,039 | 67.5% |
| 2025-07-31 | 719,980 | 1,251 | 991,994 | 72.6% |
| 2025-07-30 | 982,398 | 4,488 | 1,328,739 | 73.9% |
| 2025-07-29 | 840,665 | 611 | 1,127,354 | 74.6% |
| 2025-07-28 | 950,575 | 200 | 1,206,410 | 78.8% |
| 2025-07-25 | 1,580,852 | 2,029 | 2,976,369 | 53.1% |
| 2025-07-24 | 208,086 | 524 | 359,808 | 57.8% |
| 2025-07-23 | 370,509 | 930 | 653,642 | 56.7% |
| 2025-07-22 | 302,007 | 212 | 452,625 | 66.7% |
| 2025-07-21 | 489,543 | 101 | 967,132 | 50.6% |
| 2025-07-18 | 779,140 | 101 | 1,270,545 | 61.3% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.